COX-2 disruption leads to increased central vasopressin stores and impaired urine concentrating ability in mice

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 6, 2011, Pages

  Nørregaard, Rikke ^a   Madsen, Kirsten ^b   Hansen, Pernille B L ^b   Bie, Peter ^b   Thavalingam, Sugarna ^b   Frøkiær, Jørgen ^a   Jensen, Boye L ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Aquaporins; Water deprivation

Indexed keywords

AQUAPORIN 2; CREATININE; CYCLOOXYGENASE 2; MESSENGER RNA; UREA; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; FLUID BALANCE; HORMONE SYNTHESIS; HYPOTHALAMUS; KIDNEY COLLECTING TUBULE; KIDNEY CONCENTRATING CAPACITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UREA BLOOD LEVEL; URINE OSMOLALITY; URINE VOLUME; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; WATER DEPRIVATION;

EID: 82755162649     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00665.2010     Document Type: Article

References (52)

1. Anderson RJ, Berl T, McDonald KD, Schrier RW. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest 56: 420-426, 1975.
2. Arima H, Kondo K, Kakiya S, Nagasaki H, Yokoi H, Yambe Y, Murase T, Iwasaki Y, Oiso Y. Rapid and sensitive vasopressin heteronuclear RNA responses to changes in plasma osmolality. J Neuroendocrinol 11: 337-341, 1999.
3. Baerwolff M, Bie P. Effects of subpicomolar changes in vasopressin on urinary concentration. Am J Physiol Regul Integr Comp Physiol 255: R940-R945, 1988.
4. Baggaley E, Nielsen S, Marples D. Dehydration-induced increase in aquaporin-2 protein abundance is blocked by nonsteroidal anti-inflammatory drugs. Am J Physiol Renal Physiol 298: F1051-F1058, 2010.
5. Bie P, Sandgaard NC. Determinants of the natriuresis after acute, slow sodium loading in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278: R1-R10, 2000.
6. Biewenga WJ, Rijnberk A, Mol JA. Osmoregulation of systemic vasopressin release during long-term glucocorticoid excess: a study in dogs with hyperadrenocorticism. Acta Endocrinol (Copenh) 124: 583-588, 1991.
7. Burbach JP, Schoots O, Hernando F. Biochemistry of vasopressin fragments. Prog Brain Res 119: 127-136, 1998.
8. Chou SY, Porush JG, Faubert PF. Renal medullary circulation: hormonal control. Kidney Int 37: 1-13, 1990.
9. Christensen BM, Zelenina M, Aperia A, Nielsen S. Localization and regulation of PKA-phosphorylated AQP2 in response to V2-receptor agonist/antagonist treatment. Am J Physiol Renal Physiol 278: F29-F42, 2000.
10. Cover PO, Slater D, Buckingham JC. Expression of cyclooxygenase enzymes in rat hypothalamo-pituitary-adrenal axis: effects of endotoxin and glucocorticoids. Endocrine 16: 123-131, 2001.
11. Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378: 406-409, 1995.
12. Downey P, Sapirstein A, O'Leary E, Sun TX, Brown D, Bonventre JV. Renal concentrating defect in mice lacking group IV cytosolic phospholipase A2. Am J Physiol Renal Physiol 280: F607-F618, 2001.
13. Ecelbarger CA, Terris J, Frindt G, Echevarria M, Marples D, Nielsen S, Knepper MA. Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 269: F663-F672, 1995.
14. Ecelbarger CA, Terris J, Hoyer JR, Nielsen S, Wade JB, Knepper MA. Localization and regulation of the rat renal Na -K -2Cl- cotransporter, BSC-1. Am J Physiol Renal Fluid Electrolyte Physiol 271: F619-F628, 1996.
15. Emmeluth C, Drummer C, Gerzer R, Bie P. Natriuresis in conscious dogs caused by increased carotid [Na] during angiotensin II and aldosterone blockade. Acta Physiol Scand 151: 403-411, 1994.
16. Fenton RA, Brond L, Nielsen S, Praetorius J. Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney. Am J Physiol Renal Physiol 293: F748-F760, 2007.
17. Fenton RA, Chou CL, Stewart GS, Smith CP, Knepper MA. Urinary concentrating defect in mice with selective deletion of phloretin-sensitive urea transporters in the renal collecting duct. Proc Natl Acad Sci USA 101: 7469-7474, 2004.
18. Fleming EF, Athirakul K, Oliverio MI, Key M, Goulet J, Koller BH, Coffman TM. Urinary concentrating function in mice lacking EP3 receptors for prostaglandin E2. Am J Physiol Renal Physiol 275: F955-F961, 1998.
19. Friis UG, Madsen K, Svenningsen P, Hansen PB, Gulaveerasingam A, Jorgensen F, Aalkjaer C, Skott O, Jensen BL. Hypotonicity-induced Renin exocytosis from juxtaglomerular cells requires aquaporin-1 and cyclooxygenase-2. J Am Soc Nephrol 20: 2154-2161, 2009.
20. Gazis D, Sawyer WH. Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats. J Endocrinol 78: 179-186, 1978.
21. Guan Y, Zhang Y, Breyer RM, Fowler B, Davis L, Hebert RL, Breyer MD. Prostaglandin E2 inhibits renal collecting duct Na absorption by activating the EP1 receptor. J Clin Invest 102: 194-201, 1998.
22. Hao CM, Komhoff M, Guan Y, Redha R, Breyer MD. Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival. Am J Physiol Renal Physiol 277: F352-F359, 1999.
23. Hashimoto H, Noto T, Nakajima T. Effects of prostaglandin E2 and D2 on the release of vasopressin and oxytocin. Prostaglandins Leukot Essent Fatty Acids 36: 9-14, 1989.
24. Hebert RL, Jacobson HR, Breyer MD. PGE2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation. Am J Physiol Renal Fluid Electrolyte Physiol 259: F318-F325, 1990.
25. Hebert RL, Jacobson HR, Fredin D, Breyer MD. Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol Renal Fluid Electrolyte Physiol 265: F643-F650, 1993.
26. Hocher B, Merker HJ, Durr JA, Schiller S, Gross P, Hensen J. Internalization of V2-vasopressin receptors in LLC-PK1 cells: evidence for receptor-mediated endocytosis. Biochem Biophys Res Commun 186: 1376-1383, 1992.
27. Hristovska AM, Rasmussen LE, Hansen PB, Nielsen SS, Nusing RM, Narumiya S, Vanhoutte P, Skott O, Jensen BL. Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase. Hypertension 50: 525-530, 2007.
28. Ishikawa S, Saito T, Yoshida S. The effect of prostaglandins on the release of arginine vasopressin from the guinea pig hypothalamo-neurohypophyseal complex in organ culture. Endocrinology 108: 193-198, 1981.
29. Jensen BL, Mann B, Skott O, Kurtz A. Differential regulation of renal prostaglandin receptor mRNAs by dietary salt intake in the rat. Kidney Int 56: 528-537, 1999.
30. Kennedy CR, Xiong H, Rahal S, Vanderluit J, Slack RS, Zhang Y, Guan Y, Breyer MD, Hebert RL. Urine concentrating defect in prostaglandin EP1-deficient mice. Am J Physiol Renal Physiol 292: F868-F875, 2007.
31. Knigge U, Kjaer A, Kristoffersen U, Madsen K, Toftegaard C, Jorgensen H, Warberg J. Histamine and prostaglandin interaction in regulation of oxytocin and vasopressin secretion. J Neuroendocrinol 15: 940-945, 2003.
32. Li C, Wang W, Summer SN, Cadnapaphornchai MA, Falk S, Umenishi F, Schrier RW. Hyperosmolality in vivo upregulates aquaporin 2 water channel and Na-K-2Cl co-transporter in Brattleboro rats. J Am Soc Nephrol 17: 1657-1664, 2006.
33. Li JH, Chou CL, Li B, Gavrilova O, Eisner C, Schnermann J, Anderson SA, Deng CX, Knepper MA, Wess J. A selective EP4 PGE2 receptor agonist alleviates disease in a new mouse model of X-linked nephrogenic diabetes insipidus. J Clin Invest 119: 3115-3126, 2009.
34. Lote CJ, Haylor J. Eicosanoids in renal function. Prostaglandins Leukot Essent Fatty Acids 36: 203-217, 1989.
35. Mattson DL. Long-term measurement of arterial blood pressure in conscious mice. Am J Physiol Regul Integr Comp Physiol 274: R564-R570, 1998.
36. Morris M, Li P, Callahan MF, Oliverio MI, Coffman TM, Bosch SM, Diz DI. Neuroendocrine effects of dehydration in mice lacking the angiotensin AT1a receptor. Hypertension 33: 482-486, 1999.
37. Nielsen J, Kwon TH, Praetorius J, Frøkiær J, Knepper MA, Nielsen S. Aldosterone increases urine production and decreases apical AQP2 expression in rats with diabetes insipidus. Am J Physiol Renal Physiol 290: F438-F449, 2006.
38. Norregaard R, Jensen BL, Li C, Wang W, Knepper MA, Nielsen S, Frøkiær J. COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction. Am J Physiol Renal Physiol 289: F322-F333, 2005.
39. Norregaard R, Jensen BL, Topcu SO, Nielsen SS, Walter S, Djurhuus JC, Frøkiær J. Cyclooxygenase type 2 is increased in obstructed rat and human ureter and contributes to pelvic pressure increase after obstruction. Kidney Int 70: 872-881, 2006.
40. Norwood VF, Morham SG, Smithies O. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. Kidney Int 58: 2291-2300, 2000.
41. Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323-328, 2006.
42. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 110: 61-69, 2002.
43. Sander-Jensen K, Mehlsen J, Secher NH, Bach FW, Bie P, Giese J, Schwartz TW, Trap-Jensen J, Warberg J. Progressive central hypovolaemia in man-resulting in a vasovagal syncope? Haemodynamic and endocrine variables during venous tourniquets of the thighs. Clin Physiol 7: 231-242, 1987.
44. Sander-Jensen K, Secher NH, Astrup A, Christensen NJ, Giese J, Schwartz TW, Warberg J, Bie P. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol Regul Integr Comp Physiol 251: R742-R748, 1986.
45. Schmidt-Nielsen B, Graves B, Roth J. Water removal and solute additions determining increases in renal medullary osmolality. Am J Physiol Renal Fluid Electrolyte Physiol 244: F472-F482, 1983.
46. Shibuya I, Setiadji SV, Ibrahim N, Harayama N, Maruyama T, Ueta Y, Yamashita H. Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones. J Neuroendocrinol 14: 64-72, 2002.
47. Sladek CD, Armstrong WE. Gamma-aminobutyric acid antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants. Endocrinology 120: 1576-1580, 1987.
48. Summy-Long JY, Bui V, Gestl S, Kadekaro M. Nitric oxide, interleukin and prostaglandin interactions affecting the magnocellular system. Brain Res 940: 10-20, 2002.
49. Yamaguchi K, Hama H, Watanabe K. Possible roles of prostaglandins in the anteroventral third ventricular region in the hyperosmolality-evoked vasopressin secretion of conscious rats. Exp Brain Res 113: 265-272, 1997.
50. Yang T, Endo Y, Huang YG, Smart A, Briggs JP, Schnermann J. Renin expression in COX-2-knockout mice on normal or low-salt diets. Am J Physiol Renal Physiol 279: F819-F825, 2000.
51. Yang T, Huang YG, Ye W, Hansen P, Schnermann JB, Briggs JP. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am J Physiol Renal Physiol 288: F1125-F1132, 2005.
52. Zhang MZ, Wang JL, Cheng HF, Harris RC, McKanna JA. Cyclooxygenase- 2 in rat nephron development. Am J Physiol Renal Physiol 273: F994-F1002, 1997.